It is common knowledge in the pharmaceutical industry that the quality of a company's compound collection has a major influence on the success of biological screening in drug discovery programs. DMSO is the widely accepted solvent of choice for storage of compounds, despite the hygroscopic nature of the solvent, which can lead to stability issues. Other factors that can affect compound stability (e.g., degradation, precipitation) include concentration of compound, intrinsic compound stability, presence of reactive contaminants, storage format-related factors (vessel, sealing, etc.), storage conditions (temperature, humidity, freeze-thaw technique and cycles, etc.), and storage time. To define the best practice for the storage and handling of solution samples, GlaxoSmithKline has undertaken stability experiments over more than a decade, initially to support the implementation of new automated liquid stores (ALS) and, subsequently, to enhance storage and use of compounds in solution through an understanding of compound degradation under storage and assay conditions. The experiments described used a number of technologies, including hyphenated liquid chromatography, electrospray mass spectrometry, flow chemiluminescence nitrogen detection, nuclear magnetic resonance, and Karl Fischer titration. (Journal of Biomolecular
INTRODUCTION
T he quality of a company's compound collection has a major influence on the success of biological screening. The quality of corporate collections, particularly those that have been assembled over time, can be affected by compounds that have degraded because of their storage conditions. This is often due to a lack of knowledge or consideration of compound stability at the time of inclusion, thereby giving rise to screening collections containing "bad" compounds. It has been calculated that screening "bad" samples (where "bad" samples can be considered as impure, duplicated, or structurally incorrect) results in considerable waste in screening costs. Furthermore, the intangible costs associated with pursuing false hits can be very high.
The concept design for the Glaxo liquid store and its subsequent automation was initiated in 1994. To enable highthroughput screening (HTS), the bottleneck of compound solubilization needed to be removed. Samples were needed to be available in solution in formats amenable to high-throughput plate replication and cherry-picking. At that time, there was no published data on sample stability in solvents or conditions for storage and automation of compound handling. Consequently, experiments were implemented to validate conditions for storage and automation of compound supply for HTS. The concept design focused on long-term storage at -20 °C in 96-well blocks and included a paradigm shift in the industry, to store compounds in 384-well plates to facilitate rapid access. A key component of the strategy was to determine how long 384well plate storage was viable prior to being replenished and what were the most effective storage conditions. No suitable plasticware was available at that time to support this concept, so the project also required custom development of 96-well and 384 deep-well plates. Both the 96 and 384 storage plates were custom designed to the GlaxoSmithKline (GSK) specification by Greiner. The 384-well storage plate held a maximum of 150 µL of material, and at the time, there was no evidence that other companies were storing samples in 384-well formats. The 96-well storage block was also custom designed so as to hold 4 mL of material.
Three main areas of experimentation are described in this article. The early studies were initiated prior to the development of automated liquid stores (ALS) to guide the concept design and focused on the effect of storage time and temperature. Further experiments were initiated during the implementation and setup of the stores to mimic selected conditions and to provide long-term stability data. Later experiments monitored the control of the process and maintenance of the collection following implementation.
The first of the early experiments examined the stability of 530 structurally diverse compounds by nuclear magnetic resonance (NMR) at ambient temperature and at 4 °C. This experiment was followed up with a study of compounds in ALS formats and plasticware since the original data had been obtained in NMR tubes. The vision was to generate long-term DMSO stability data to support storage of DMSO stock solutions for at least 5 years. A long-term stability study was set up in January 2000 on 310 structurally diverse compounds stored in the master liquid store (MLS) with flexibility to select time points based on the emerging patterns and stability data produced.
The next series of experiments, using a subset of compounds from the long-term stability study, examined effects of freezethawing on stability and effects of lidding versus sealing; this, together with the findings from the GSK Quality Assurance project 1 to analyze all solution samples to form the new GSK screening collection, helped refine conditions within our systems and processes.
The last series of experiments has assessed the integrity of material held in production systems by testing samples from hit quality control (QC) follow-up, random selections of 10-mM compound solutions held in Abgene tubes from worldwide tube stores, and 384-well storage plates from ALS working stores.
MATERIALS AND METHODS

Compound selection
To support the early experiments, we selected a list of compounds based on having >50 mg available from the solid compound store and randomly selected them based on structural diversity. The final number of compounds analyzed for each experiment was based on a balance between sufficient numbers versus available resources. For subsequent experiments, used to monitor the current GSK DMSO collection, a random set was again generated, but compounds showing activity following HTS were also used.
Materials
For the initial NMR experiment, 4 to 5 mg of fresh solid was obtained from the GSK compound store, dissolved in 1200 µL of DMSO-d 6 , agitated to help solvation and sonicated if required. For this and all subsequent experiments, DMSO is 100% DMSO. The solution was split equally between 2 NMR tubes, sealed, and then stored at the appropriate temperature.
For the liquid chromatography/mass spectrometry (LC/ MS) experiments, including the long-term stability experiment, 40 µmol (±10%) of solid was solvated with DMSO (4 mL) to give a concentration of 10 mM. The 10-mM dissolved samples were transferred to a 96-well central liquid store (CLS) block and sealed with a Beckman foil seal. Identical conditions for solvation were used for the sealed/lidded experiment, and the dissolved samples were transferred to a 384-well Greiner plate with half of the plates being sealed with a Beckman foil seal and the other half with a loose-fitting lid. For the freeze-thaw experiment, 10 µmol (±10%) of solid was solvated with DMSO (5 mL) to give a concentration of 2 mM. Then, 125 µL of the 2-mM DMSO solution was transferred to a 384-well highdensity store (HDS) block and lidded. For the final validation experiments, 384-well Greiner plates and Abgene septumsealed tubes containing 25 µL of 10 mM DMSO were obtained from the liquid store for analysis.
Experimental protocol: stability studies
1. NMR study. Two identical solutions of each of the selected 530 compounds were made up in DMSO-d 6 as described previously. One was stored at 4 °C as a frozen solution; the other was stored at room temperature. 1 H NMR spectra were recorded on the samples over the following time period: a room temperature measurement was taken at time 0, 1 month, and 4½ months. A 4 °C measurement was taken at 1 month and after 6 months on samples that had shown significant degradation after 4½ months at room temperature.
2.
The 384-well plate study. In total, 585 DMSO solutions (10 mM) were stored in 384-well (HDS) blocks (150 µL) at 4 °C and 17% relative humidity (RH); the lowest humidity that can be reached in a laboratory fridge 2 ) and at -20 °C for up to 6 months and analyzed at 1-month, 3-month, and 6-month time points. To monitor the long-term stability of archive plates, we stored 310 DMSO solutions (10 mM) sealed using a Beckman foil seal in 96 deep-well blocks (2 mL) at -20 °C in the master liquid store and analyzed at 3-month, 6-month, 1-year, 2-year, and 6-year time points. LC/MS analysis was used to measure the degradation of the compounds over time, and in all studies, a time 0 measurement was obtained in duplicate.
3. Effect of freeze-thawing on stability. 3 To investigate the effect of storage time and number of freeze-thaw cycles on degradation, we selected 160 samples from those used in the ALS -20 °C long-term stability experiment. These were stored in 384 deep-well blocks (125 µL) at 2 mM and 5% RH in the HDS. Due to the large number of variables, a factorial design experiment was used. Factorial designs are used primarily for screening significant factors, such as storage time and temperature, but can also be used sequentially to model and refine a process. A response surface regression analysis was performed to assess the linear and quadratic effects of freeze-thawing and time. The response used in the analysis was the square root of the proportion of compound not degraded. This experiment used 17 combinations of freeze-thaw cycles and storage time. The limits of the factors of the experiment were from 2 weeks to 6 months (storage time) and from 5 to 25 freeze-thaw cycles. Identical 384 deep-well HDS blocks were prepared and deposited in the automated liquid store area. There were 80 samples on each block, and DMSO was added to the empty wells to check for water uptake. Control samples were also added to the blocks and were replicated on each block. Two blocks were analyzed by LC/MS immediately so a time 0 result could be obtained in duplicate. At each time point or freezethaw cycle, a block was taken out of the ALS area, allowed to thaw, and then analyzed. One block remained in the store as the control and did not undergo any freeze-thaw cycles. Each freeze-thaw cycle took 90 min. Following LC/MS analysis of the samples, the areas under the UV peak were recorded as the responses, and the software determined the effects of freezethawing and storage time on the degradation of samples. 4 To investigate the effect of sealing versus lidding plates, we selected another subset of 160 samples from those used in the ALS -20 °C long-term stability experiment. An additional set of 80 unstable compounds was selected to form a biased set, picked from previous stability studies in which each compound had demonstrated some instability/precipitation in DMSO upon storage. The 240 samples were distributed in 384 deep-well blocks (80 samples per block being surrounded by DMSO). Blocks were covered using 1 of 2 methods: Beckman foil seal technology (i.e., sealed) or Greiner universal loose-fitting lid (i.e., lidded). The samples were stored in a fridge at 4 °C without humidity control up to 3 months with LC/MS and Karl Fischer analysis at time 0, 1-month, 2-month, and 3-month time points. An extra LC/MS analysis time point at 6 months was included to enhance the data set.
Effect of sealing or lidding plates on stability.
For the final experiments, following the results of a highthroughput screen, the actives of interest were ordered from the appropriate store to check the sample integrity in the production systems. Then, 25 µL of 10 mM DMSO solution was dispensed from the UK Large Tube Store (Abgene tubes at -20 °C) in a 384-well Greiner plate for LC/MS analysis. Also, a random selection of 200 compounds by year of solvation date (2004) (2005) (2006) (2007) (2008) was ordered from the worldwide stores (Harlow, UK; Tres Cantos, Spain; and Upper Providence, PA) for both the tubes and the archive plates to validate fully the storage conditions in the production systems globally. These samples were prepared centrally from solids and had undergone freeze-thaw cycles on different occasions for access by local scientists. Both the tubes and plates had also been stored at 10 mM and -20 °C with, again, analysis of water content using the Echo 555 carried out, but also an additional measurement for concentration was made using flow chemiluminescence nitrogen detection (fCLND).
Analytical procedure
For the initial NMR experiment, 1 H NMR spectra were recorded using a Bruker AM 250-MHz spectrometer (Bruker BioSpin, Coventry, UK). Standard parameters were used for each sample (30° pulse width, 1.6-s acquisition time, 16K data points collected, 96 scans, 0.3-Hz line broadening). The spectra were recorded at room temperature (20 °C). Typical acquisition time for each sample, including time for shimming and locking the sample, was 10 min. Samples were checked for precipitation before acquisition. The initial purity of the sample was determined at time 0 from the ratio of the integral of a signal in the major component to the sum of the integrals from a signal from each component expressed as a percentage:
where M is the major component, and m is the minor component(s). Subsequent spectra at the different time points were examined to determine if there were any differences from the time 0 spectrum and to see if there were any signs of sample decomposition and to what extent. The extent of compound decomposition was determined from the ratio of an integral of a signal from the original compound to the sum of the integrals of a peak associated with each decomposition product and the integral of a peak from the original compound.
For the analysis of water uptake over time, the measurement for the early experiments used Karl Fischer titration 5,6 and a Mitsubishi Moisture Meter Model CA-100 (Mitsubishi Chemical Corporation, Tokyo, Japan). A check solution P (20 µL), obtained from Mitsubishi Chemical Corporation containing a known amount of water (76-84 µg H 2 O), was titrated at the beginning, middle, and end of the experiment to ensure the instrument was fit for purpose. For the later experiments, the measurement of water was carried out via well fluid acoustic impedance 7 using the Echo 555 (Labcyte, Sunnyvale, CA). This is a fast, nondestructive technique and enabled the sample to be used for other measurements following the water analysis.
For the early LC/MS experiments, analysis plates were prepared by mixing 100-µL aliquots of 10 mM DMSO solution with 900 µL DMSO to give a concentration of 1 mM in a 96-well microplate. For the later experiments, 50 µL of 10 mM DMSO solution was diluted to 500 µL in a 96-well block to give a concentration of 1 mM. For the freeze-thaw study, no dilution was required as the 384-well HDS block containing 125 µL of 2 mM DMSO solution was used.
For the early stability experiments, the LC/MS system comprised a Gilson 233XL autosampler (Gilson, Middleton, WI), a Hewlett Packard HPLC system (Hewlett Packard, Sunnyvale, CA) fitted with a 3-µm Supelcosil ABZ+ column (3.3 cm × 4.6 mm), and a binary LC pump and a UV diode array detector (DAD) scanning between 190 and 600 nm at 2-nm intervals. The eluent from the DAD was split at a ratio of 1:70 prior to the mass spectrometer. A Micromass Platform mass spectrometer (Waters, Manchester, UK) was used as the mass detector. The instrument was set up using a positive electrospray source (ESI) with a capillary temperature of 80 °C and a capillary voltage of 3.3 kV. Full scan mode was used for detecting ions between 100 and 1000 Da at a scan rate of 0.5 s. Data processing and analysis for purity and molecular weight confirmation were performed using Mass Lynx Openlynx Browser software (Waters). Stability measurements were performed via comparison of the diode array peak area with that of the time 0 data and in the later experiments using the difference in purity (degradation was defined as a ≥10% reduction in the purity value). LC conditions for the analytical analyses are described in Table 1 . For the later experiments, the LC/MS system comprised an Agilent HP 1100 (Agilent Technologies, Waldbronn, Germany) autosampler, an Agilent HP 1100 high-performance liquid chromatography (HPLC) system fitted with a 3.5-µm XTterra MS C18 column (2.1 cm × 30 mm), a binary LC pump, and an Agilent HP 1100 UV DAD scanning between 210 and 350 nm at 2-nm intervals. A Waters ZQ mass spectrometer was used as the mass detector. The instrument was set up using both positive and negative ionization with an ESI, a capillary temperature of 80 °C, and a capillary voltage of 3.3 kV. Full scan mode was used for detecting ions between 100 and 1000 Da at a scan rate of 0.5 s. The system was controlled using MassLynx v3.5 software.
The LC/MS instrument was validated prior to each experiment using repeat injections of a system suitability test mix 1 to check the reproducibility. During the experiments, test mixes were analyzed at the beginning, in the middle, and at the end of a batch of samples to ensure correct functioning of the instrument.
For the concentration measurements, fCLND [8] [9] [10] was used, which comprised an Agilent HP 1100 coupled to 8060-M CLND (Antek Instruments, Inc., Houston, TX) and operated with a furnace temperature of 1050 °C, ozone at 25 mL/min, and oxygen settings at 250 mL/min and inlet and makeup helium flows at 50 mL/min. The instrument response was calibrated daily using caffeine, and a standard solution of 10 mM ondansetron was used to ensure reliability of results.
Statistical analysis
It is important to analyze a statistically relevant and representative sample while making sure enough resource is available for the analysis when designing stability experiments. GSK Statistical Sciences was consulted to help define the number of samples that would need to be analyzed for each experiment.
In the freeze-thaw experiment, the square root of the proportion of compound not degraded was used as the response in response surface regression to determine the effect of time and freeze-thaw. The proportion not degraded was calculated as y (1) x where x _ is the average of ultraviolet (UV) area at time 0, and y is the UV area of the sample. The proportion was not normally distributed, so a transformation was taken and analysis of variance (ANOVA) performed on the transformed data.
The model fitted was
for each compound i, freeze j, and time k. The Type I error rate was set at 0.05. The Type I error rate is the probability of observing a difference between time or freeze-thaw cycles when, in reality, no difference exists. The normality assumption was tested by observing a plot of the residuals against predicted values and the normal quantile plot of the residuals.
For the sealed versus lidded experiment, the proportion of compound not degraded was used as the response in ANOVA. The proportion not degraded was calculated as for the freezethaw experiment. The model fitted in ANOVA was for each compound i and method j. The Type I error rate was set at 0.05. The normality assumption was tested using the Shapiro-Wilk statistic and by observing the normal quantile plot of the residuals.
RESULTS AND DISCUSSION
Effect of time and temperature on compound stability
To maintain a high-quality screening collection at GSK, all new chemical entities entering the screening collection are subject to quality control to check the purity and identity of the DMSO solution. The compound integrity standard for our collection is ≥80% purity. We have been actively quantifying our screening collections at crucial points to understand the potential source of degradation or compound losses during the drug discovery process. The aims of these stability experiments were to define conditions for building the automated solution stores and then to validate the conditions for storage and automation to support compound supply for HTS.
The initial stability study, undertaken to guide the design of the proposed ALS, comprised 530 structurally diverse compounds, stored at 4 °C and at room temperature (RT) in sealed NMR tubes. Samples were analyzed by 1 H NMR for up to 6 months; 86% of the samples were OK (sample is ≥80% pure and consistent with the registered structure) at time 0, 7% were a mixture, and 5% were pure but not consistent with the registered structure. Compounds showing no degradation after 4½ months at RT were not reanalyzed after 6 months at 4 °C as they were assumed to remain stable. The percentage of compounds held at 4 °C that had degraded by >50% after 1 month was 2%, and for those held at RT, it was 4%. This percentage increased to 8% at RT after 4½ months, whereas after 6 months at 4 °C, only 4% had degraded. The results suggest that temperature has made a difference to the stability of the compounds with approximately twice as many samples showing signs of decomposition at RT compared with those at 4 °C. From these results, it was proposed that the sample lifetime in the 4 °C, 5% relative humidity HDS was to be 3 months, and samples stored in the -20 °C MLS should have a lifetime of 5 years.
A second stability study was undertaken to investigate conditions more closely aligned with the planned ALS. In total, 585 structurally diverse compounds in DMSO were stored at 4 °C and -20 °C in 384 deep-well plates and analyzed over a 6-month timeframe. There was a significant difference after 3 months between the 8% of samples that degraded by >50% at 4 °C, compared to the 4% of samples that degraded by >50% at -20 °C (p = 0.0016). After 6 months, there was a significant difference between the 21% of samples that degraded by >50% at 4°C, compared to the 9% of samples that degraded by >50% at -20 °C (p < 0.0001).
In summary, the rate of decomposition was approximately twice as high at 4 °C than at -20 °C and demonstrates a marked decline in stability of compounds in DMSO as a function of both time and temperature. These data helped to establish initial compound storage conditions in the ALS. Compounds in the working (4 °C) store were assigned a sample lifetime of 3 months, whereas compounds in the archive (-20 °C) store were assumed stable for longer. This led to a final long-term stability study to establish how long the integrity of compounds could be maintained at -20 °C in sealed 384 deep-well blocks.
An initial set of 549 structurally diverse compounds was prescreened at 1 mg/mL in DMSO to remove compounds that were not amenable to LC/MS and samples that were clearly not soluble by observation of precipitate. A resultant set of 310 compounds was analyzed over a 6-year timeframe (Fig. 1a) , and the results show that less than 10% had degraded over that time period. Degradation was determined using the purity difference between the time 0 purity and the purities at the subsequent time points, with compounds showing a purity difference of ≥10% being reported to have degraded as this value takes into account any measurement variation within the analysis (using the >50% change as described in previous studies would not have highlighted any significant degradation). Degradation of individual compounds was not linear over time, with the greatest degradation occurring in the early months. Those compounds that showed degradation in the early months also showed significant degradation after prolonged storage. Encouragingly, 89% of compounds were still suitable for entry into the screening collection (≥80% pure and correct) after 6 years ( Fig. 1b) compared with 100% at time 0. These results predict an acceptable level of degradation by extending the storage lifetime beyond 6 years, and extrapolation of the data confirms this (12% degradation after 10 years).
Effect of freeze-thawing on compound stability
To determine the effect of freeze-thawing on compound stability, we subjected 160 compounds to between 5 and 25 freezethaw cycles over 2 weeks to 6 months (stored in the HDS at 4 °C, 5% RH), based on a central composite response surface design. Fitting a response surface regression model to the area under the UV peak showed that the compounds with greater degradation had a different distribution from the other compounds. The 20 most degraded compounds from each block were investigated separately as the freeze-thaw and storage time would be expected to have more of an effect on these compounds. The square root of the proportion of compound not degraded was used as the response in a response surface regression model. The resulting 3D plot is shown in Figure 2 , and over 6 months, the average predicted degradation increased from -16% (increase in area) to 56%. The effect of storage time was highly significant (p < 0.0001). From the plot, this can be seen as a linear increase in degradation across time. There was no evidence of increased degradation with increased number of freeze-thaws. The remaining compounds showed little degradation, but again storage time had a significant linear effect, with degradation increasing as storage time increased. These results provided GSK with the confidence that samples could be stored in the HDS at 4 °C for 3 to 4 months.
Effect of sealing or lidding plates on stability
A sealed lidded study was undertaken to investigate the effect on degradation of storing compounds with a lid or a Beckman foil seal at different time points and constant temperature. Previous studies at GSK and other companies have demonstrated that significant water uptake occurs when samples are stored unsealed in DMSO, especially in the absence of humidity control, and this phenomenon is often accompanied by sample degradation or precipitation. 11, 12 To study the effect of water uptake on compound stability and precipitation, we selected a set of 160 diverse compounds, together with a biased set of compounds, known to be unstable in DMSO. Duplicate compounds were stored in 384-well plates and either sealed or lidded and stored for 3 months at 4 °C. Average compound degradation across the plate over time is shown in Figure 3a and was determined using LC/MS. The effect of time was significant (p < 0.0001), which again shows that increased storage time causes increased degradation. Degradation was significantly higher for compounds in lidded plates compared to those that were sealed (p = 0.0079). More water uptake occurred in lidded plates than in sealed plates, and the water uptake was greater at the edges and corners of the plate compared with the center (Fig. 3b) . The greater percentage of water seen in zone A for sealed plates was due to a process error that caused incomplete sealing.
These results are backed up by the data that were generated as part of the quality assurance (QA) project 1 when, following the merger of GlaxoWellcome and SmithKline Beecham, 1.4 million compounds were analyzed by LC/MS to check the purity and identity of compounds stored in the legacy DMSO solution stores (unpublished observations show that the average water content was 2% in the inner wells and 11.7% in the corners), prior to inclusion in the new GSK screening collection. A larger population of the failures was located in well positions around the plate edge and especially corners, which correlated with the observed water uptake (see Fig. 3c ). This clearly demonstrates that under historical storage conditions in plates, decomposition is more likely to be observed at the edges and corners.
The results from the COMDECOM 13 project also back up this observation. COMDECOM (COMpound DECOMposition) is an initiative involving several pharmaceutical companies and SPECS, a commercial supplier of compounds. The project aimed to determine factors that cause compounds in DMSO to degrade under a variety of conditions with the ultimate goal of building a predictive model for compound degradation. One of the main findings from this project was that water had a greater effect on compound degradation than storage time.
All these results strongly suggest that water uptake of DMSO solutions should be minimized to lessen the probability of problems such as degradation, precipitation, and changes in concentration. This led us to the strategy to have compounds in solution available in split septum-sealed tubes, stored at -20 °C for hit follow-up.
Postproduction validation of storage conditions
To validate the chosen conditions for compound storage, samples have been analyzed throughout the years that the ALS has been in production, during the course of HTS and follow-up of compounds showing biological activity.
In total, 16,899 such compounds, stored at -20 °C in sealed tubes, were analyzed for purity and integrity by LC/MS. The results (Fig. 4a) show that >90% of the compounds surpassed our criteria (≥80% purity) for inclusion in the GSK Screening Collection. This was good evidence that the chosen storage conditions for samples in tubes were acceptable.
A small set of 200 randomly chosen samples in tubes was investigated for water uptake and compound concentration and ordered by solvation date from the compound stores globally. The results (Fig. 4b) show that the average water content was 9.4%, and the average concentration of the DMSO solution was 8 mM (compared to a nominal concentration of 10 mM). A set of archive plates (compounds at 10 mM in 384 deep-well plates stored sealed at -20 °C) for the same 200 randomly selected samples was also analyzed for water uptake and compound concentration. Results show the average water content was 11%, and the average concentration of the DMSO solution was 7.7 mM. This demonstrates that there is no significant difference in either water content or concentration in tubes and plates. In addition, no significant difference between the storage sites globally was observed. The results confirm that the chosen storage conditions in the production systems for both the tubes and plates are fit for purpose. 
CONCLUSION
In the mid-1990s, when this work was initiated, little information was known about the effects of long-term storage in DMSO and the best conditions to optimize the "shelf life" of compound collections. Solution storage at GSK is based on storage of samples in tubes and plates in automated systems, and the conditions were devised based on the output of the experiments described in this article. In addition, they reflect a pragmatic strategy to facilitate high-throughput supply of assay-ready plates.
A key finding of these studies and others [14] [15] [16] is that time of storage and temperature are critical factors in compound stability. Water uptake is an important factor and causes sample degradation and/or precipitation, findings that are also corroborated by others. 11, 12, 17, 18 It is interesting, however, that Engeloch et al 15 stored solutions at 2 mM in a DMSO/water (90/10%) mix, without substantial reduction in sample quality, although the authors did not elaborate on the difference between their results and those of others. However, we have measured water uptake during preparation of our solutions, and the results in Figure 4b show that plates and tubes in our stores contain approximately 10% water on average and have demonstrated stability. It is likely that a combination of low concentration and limited water uptake will help to minimize sample degradation and precipitation from solution.
Our studies also showed that freeze-thawing is not correlated with sample stability. These last findings are in contrast to previous studies, 19 where we believe that the reported sample instability may have been due to water uptake rather than freeze-thawing. In a normal production environment, every time a sample is thawed and then accessed by removing the seal, water uptake is likely to occur. This may result in the erroneous conclusion that freeze-thawing contributes to sample degradation, whereas water uptake may be the cause. For this reason, it is important to measure water uptake when trying to correlate freeze-thawing with sample stability.
The shelf life of solution sample collections has to be a balance between storage of compounds for as long as possible (compound cost/full-time equivalent [FTE] resource to replenish collection) and removing compounds once they have reached the end of shelf life (cost of screening poor-quality compounds). Data presented here indicate that long-term storage is viable and that the rate of degradation decreases significantly after the first 2 years. Consequently, GSK's goal is to store and maintain master 10-mM DMSO stocks for >7 years while replenishing 1-mM plate-based stocks for HTS supply every 4 months. The postproduction checks that GSK has in place validate storage conditions and indicate no significant differences between tube and plate-based storage.
